November 10, 2016
BD and JDRF join forces to fight type 1 diabetes
BD has announced a new research collaboration supported by JDRF, the global organization funding…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: diabetes
November 8, 2016
BD launches first syringe designed for use with Humulin R U-500 insulin
BD has announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin …
February 22, 2016
FDA Accepts Sanofi NDA for Combination of Insulin Glargine and Lixisenatide (diabetes)
The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Sanofi’s investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 diabetes.
December 17, 2015
Lilly’s and Boehringer Ingelheim’s insuline injection gets FDA’s nod
Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) were granted approval by the U.S. Food and Drug Administration (FDA) for Basaglar (insulin glargine injection) 100 units/mL.
December 4, 2015
Lilly quits developing basal insulin peglispro
Eli Lilly and Company will cease development of basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, in order to focus research and development efforts on other assets in its portfolio and pipeline.
November 20, 2015
Janssen applies to FDA New Drug Application for Invokamet XR
Janssen Research & Development, LLC has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Invokamet extended release (XR).
November 6, 2015
Sanofi and Lexicon to develop sotagliflozin (for diabetics)
Sanofi and Lexicon Pharmaceuticals have entered into a collaboration and license agreement for the development and commercialization of sotagliflozin, an investigational new oral dual inhibitor of sodium-glucose cotransporters 1 and 2 (SGLT-1 and SGLT-2), which could be a potential treatment option for people with diabetes.
September 28, 2015
TF Supplements recalls Rhino 7 bottle with 6 capsules
FDA has announced that the TF Supplements of Houston is voluntarily recalling the following product to the consumer level: RHINO…